This study was supported by National Natural Science Foundation of China (82171808, 82200369), Natural Science Foundation of Beijing (7232022), the Capital’s Funds for Health Improvement and Research (2024-1-2051), the Leading Talent Program in High-level Public Health Technical Talents of Beijing (Lingjunrencai-03-02), Capital Medical University Clinical Specialty College/Department Training Fund Program (CCMU2022ZKYXY004), the Priming Scientific Research Foundation for the Junior Researcher in Beijing Tongren Hospital, Capital Medical University (2021-YJJ-ZZL-001, 2022-YJJ-ZZL-015, 2022-YJJ-ZZL-051).
Chen Lu, Jiang Xue, Guo Xinying, Liu Jian, Guo Caixia. Risk factors and prognostic implications of acute myocardial infarction complicated with pericardial effusion[J]. Journal of Capital Medical University, 2025, 46(6): 1033-1043.
[1]中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J]. 中华心血管病杂志, 2019, 47(10): 766-783.
[2]Byrne R A, Rossello X, Coughlan J J, et al. 2023 ESC guidelines for the management of acute coronary syndromes[J]. Eur Heart J, 2023, 44(38): 3720-3826.
[3]Rao S V, O'Donoghue M L, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines[J]. Circulation, 2025, 151(13): e771-e862.
[4]Bière L, Mateus V, Clerfond G, et al. Predictive factors of pericardial effusion after a first acute myocardial infarction and successful reperfusion[J]. Am J Cardiol, 2015, 116(4): 497-503.
[5]Klein A L, Wang T K M, Cremer P C, et al. Pericardial diseases: international position statement on new concepts and advances in multimodality cardiac imaging[J]. JACC Cardiovasc Imaging, 2024, 17(8): 937-988.
[6]Hoit B D. Pericardial effusion and cardiac tamponade in the new millennium[J]. Curr Cardiol Rep, 2017, 19(7): 57.
[7]Schulz-Menger J, Collini V, Gröschel J, et al. 2025 ESC guidelines for the management of myocarditis and pericarditis[J]. Eur Heart J, 2025, 46(40): 3952-4041.
[8]Albani S, Fabris E, Stolfo D, et al. Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience[J]. Eur Heart J Acute Cardiovasc Care, 2021, 10(1): 71-80.
[9]中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 非ST段抬高型急性冠脉综合征诊断和治疗指南(2024)[J]. 中华心血管病杂志, 2024, 52(6): 615-646.
[10]Yuksel Y, Yildiz C, Kose S. Assessment of predictive value of SYNTAX-II Score for adverse cardiac events and clinical outcomes in patients with acute coronary syndrome[J]. Angiology, 2024, 75(8): 754-763.[11]Ang D T Y, Carberry J, Ford T J, et al. Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trial[J]. Heart, 2025, 111(3): 117-124.
[12]Zheng J Y, Yu X, Zhou D Z, et al. Prevalence and contributing factors associated with tricuspid regurgitation among patients underwent echocardiography assessment[J]. BMC Cardiovasc Disord, 2024, 24(1): 552.
[13]Klein A L, Abbara S, Agler D A, et al. American society of echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the society for cardiovascular magnetic resonance and society of cardiovascular computed tomography[J]. J Am Soc Echocardiogr, 2013, 26(9): 965-1012, e15.
[14]Gaudino M, Franco A D, Rong L Q, et al. Pericardial effusion provoking atrial fibrillation after cardiac surgery: JACC review topic of the week[J]. J Am Coll Cardiol,2022, 79(25): 2529-2539.